Junteng Technology

Founded in 2015 and based in Jinan, China, Junteng Technology operates as a medical technology company that focuses on rapid pathology solutions. It acquired certifications such as ISO9001, ISO13485, and CE certifivate. The company has obtained the National High-tech Enterprise Certification and the National Specialized and New Small Giant Enterprise Certification, and has obtained 106 intellectual property rights and 18 invention patents. In March 2025, Jianteng Technology closed venture funding from new investor Jinan Jingfa Capital.

The company specializes in the research, development, production, and sales of rapid pathology products. Products include rapid tissue dehydration equipment, fully automatic embedding equipment, staining and sealing equipment, and numbering equipment. Rapid tissue dehydration equipment includes fully automatic rapid tissue dehydration machines and pathological sample pre-analysis dehydration and embedding machines. Numbering equipment includes embedding box numbering machine HT-CP1 and slide numbering machine HT-SP1.

Products can be used in pathological diagnosis, hospital pathology departments, scientific research institutions, and other fields. The company generates revenue by providing rapid pathology products such as rapid tissue dehydration equipment, fully automatic embedding equipment, and numbering equipment.   The company plans to launch new rapid pathology products, enhancing their current offerings. Junteng Technology aims to expand into international markets, particularly focusing on regions in Southeast Asia and Europe by the end of 2026.

It will use the venture funding to support these product developments and market expansions.